ac22 - explore signaling pathways and combination therapy in fgfr2-activated cholangiocarcinoma
Published 2 years ago • 121 plays • Length 10:39Download video MP4
Download video MP3
Similar videos
-
1:31:06
ac22 - session iii :: targeted therapies and overcoming resistance
-
1:00:01
webinar: targeting the fgfr pathway: infigratinib in cholangiocarcinoma
-
19:15
ac22 - scientific update
-
11:05
ac22 - clonal origins of metastatic cholangiocarcinoma
-
4:13
ac22 - history of cholangiocarcinoma foundation research fellowship program
-
10:53
ac22 - deep immune profiling of intrahepatic cholangiocarcinoma with codex multiplexed imaging
-
2:01
fgfr mutations
-
27:04
webinar: first-in human-studies of fgfr inhibitor kin-3248 and raf inhibitor kin-2787
-
1:05:02
ac22 - session ii :: studying the neighborhood: lessons from the tumor microenvironment
-
11:12
2017 ccf annual conference #12 - day 2 - grantee report: a hippo and fgfr autocrine pathway in cca
-
4:12
fgfr2 inhibitors in advanced cholangiocarcinoma
-
2:30
dr. michael comb discusses cell signaling pathways and their role in cancer
-
51:50
2018 cholangiocarcinoma foundation annual conference #5 - day 1 - immunotherapies
-
1:09:59
ac20 - clinical trials
-
0:47
gpcr signaling explained in 1 minute | gpcr signaling pathway | cell bio in 1 minute
-
1:43
bile duct cancer research from dana-farber cancer institute
-
2:31
efficacy of second-line chemotherapy in advanced cca with fgfr2 fusions
-
1:29
interplay between the hgfc-met and hedgehog pathways and implications for cancer treatment